home / stock / nlsp / nlsp news

NLSP News and Press, NLS Pharmaceutics Ltd. From 04/19/24

Stock Information
Company Name: NLS Pharmaceutics Ltd.
Stock Symbol: NLSP
Market: NASDAQ
Website: nlspharma.com
Menu
NLSP NLSP Quote NLSP Short NLSP News NLSP Articles NLSP Message Board
Get NLSP Alerts

News, Short Squeeze, Breakout and More Instantly...
NLSP - NLS Pharmaceutics receives Nasdaq staff delisting determination

2024-04-19 17:10:25 ET More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further det...
NLSP - NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering

ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervo...

NLSP - US Companies Moving the Markets, Evening edition
Wed, Mar 20, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...

NLSP - NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
NLSP - US Companies Moving the Markets, Morning edition
Wed, Mar 20, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 28.7% to $0.0887 on volume of 95,670,653 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 21.5% to $0.0243 on volume of 91,833,714 shares Oblong Inc. (OBLG) rose 45.2% to $0.19605 on volume of 60,847,1...

NLSP - NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform

The exclusive License Agreement grants NLS Pharmaceutics global rights to next-generation non-sulfonamide orexin-1 / orexin-2 receptor agonists, tailored to target multiple pathways in neuropharmacological therapies. Medications activating dual OX1R/OX2R target a broader range of mechanisms ...

NLSP - NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event

ZURICH, SWITZERLAND / ACCESSWIRE / March 14, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
NLSP - Nasdaq accepts NLS pharmaceutics' plan to regain listing compliance

2024-03-11 07:31:15 ET More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further det...

NLSP - Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance

ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...

NLSP - NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq

ZÜRICH, SWITZERLAND / ACCESSWIRE / February 23, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central ne...
Previous 10 Next 10